INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
Table of contents
- 1
-
A remembrance of Rupert K. A. Schmidt-Ullrich, M.D.Wazer, D. E. et al. | 2005
- 3
-
Evidence-based review of three-dimensional conformal radiotherapy for localized prostate cancer: An ASTRO outcomes initiativeMorris, D. E. / Emami, B. / Mauch, P. M. et al. | 2005
- 20
-
Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapyLaprie, A. / Pirzkall, A. / Haas-Kogan, D. A. et al. | 2005
- 32
-
Gamma knife radiosurgery of radiation-induced intracranial tumors: Local control, outcomes, and complicationsJensen, A. W. / Brown, P. D. / Pollock, B. E. et al. | 2005
- 38
-
Where to locate the isocenter? The treatment strategy for repeat trigeminal neuralgia radiosurgeryZhang, P. / Brisman, R. / Choi, J. et al. | 2005
- 44
-
Stereotactic proton beam therapy for intracranial arteriovenous malformationsVernimmen, F. J. / Slabbert, J. P. / Wilson, J. A. et al. | 2005
- 53
-
Multifractionated image-guided and stereotactic intensity-modulated radiotherapy of paraspinal tumors: A preliminary reportYamada, Y. / Lovelock, D. M. / Yenice, K. M. et al. | 2005
- 62
-
Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3Terhaard, C. H. / Kal, H. B. / Hordijk, G. J. et al. | 2005
- 70
-
Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non–small-cell lung cancer?Fox, J. L. / Rengan, R. / O’ et al. | 2005
- 76
-
Phase II study of radiotherapy with three-dimensional conformal boost concurrent with paclitaxel and cisplatin for Stage IIIB non-small-cell lung cancerKim, Y. S. / Yoon, S. M. / Choi, E. K. et al. | 2005
- 82
-
Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: Report of 549 casesXiao, Z. F. / Yang, Z. Y. / Miao, Y. J. et al. | 2005
- 91
-
Phase I trial of oxaliplatin in combination with cisplatin, protacted-infusion fluorouracil, and radiotherapy in advanced esophageal and gastroesophageal carcinomaMaurel, J. / Cervantes, A. x. / Conill, C. et al. | 2005
- 97
-
Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinomaKeene, K. S. / Rich, T. A. / Penberthy, D. R. et al. | 2005
- 104
-
Consolidative abdominopelvic radiotherapy after surgery and carboplatin/paclitaxel chemotherapy for epithelial ovarian cancerDinniwell, R. / Lock, M. / Pintilie, M. et al. | 2005
- 111
-
Intravaginal brachytherapy alone for intermediate-risk endometrial cancerAlektiar, K. M. / Venkatraman, E. / Chi, D. S. et al. | 2005
- 118
-
Fractionated stereotactic radiotherapy boost for gynecologic tumors: An alternative to brachytherapy?Mollà / M. / Escude, L. x. et al. | 2005
- 125
-
High-dose-rate brachytherapy in uterine cervical carcinomaPatel, F. D. / Rai, B. / Mallick, I. et al. | 2005
- 131
-
Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancerPelloski, C. E. / Palmer, M. / Chronowski, G. M. et al. | 2005
- 138
-
Definitive radiation therapy for squamous cell carcinoma of the vaginaFrank, S. J. / Jhingran, A. / Levenback, C. et al. | 2005
- 148
-
PSA doubling time kinetics during prostate cancer biochemical relapse after external beam radiation therapyBates, A. T. / Pickles, T. / Paltiel, C. et al. | 2005
- 154
-
An automatic CT-guided adaptive radiation therapy technique by online modification of multileaf collimator leaf positions for prostate cancerCourt, L. E. / Dong, L. / Lee, A. K. et al. | 2005
- 164
-
Prophylactic tamsulosin (Flomax) in patients undergoing prostate 125I brachytherapy for prostate carcinoma: Final report of a double-blind placebo-controlled randomized studyElshaikh, M. A. / Ulchaker, J. C. / Reddy, C. A. et al. | 2005
- 170
-
High-dose regions versus likelihood of cure after prostate brachytherapyWallner, K. / Merrick, G. / Sutlief, S. et al. | 2005
- 175
-
Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomyTruong, P. T. / Lesperance, M. / Culhaci, A. et al. | 2005
- 183
-
1998–1999 Patterns of Care Study process survey of national practice patterns using breast-conserving surgery and radiotherapy in the management of Stage I-II breast cancerPierce, L. J. / Moughan, J. / White, J. et al. | 2005
- 193
-
Results of breast conservation therapy from a single-institution community hospital in Hawaii with a predominantly Japanese populationKanemori, M. / Prygrocki, M. et al. | 2005
- 198
-
Intensity-modulated radiotherapy for lymphoma involving the mediastinumGoodman, K. A. / Toner, S. / Hunt, M. et al. | 2005
- 207
-
Hypoxia-induced radioresistance is independent of hypoxia-inducible factor-1A in vitroArvold, N. D. / Guha, N. / Wang, D. et al. | 2005
- 213
-
Dual responsive promoters to target therapeutic gene expression to radiation-resistant hypoxic tumor cellsChadderton, N. / Cowen, R. L. / Sheppard, F. C. et al. | 2005
- 223
-
Modulation of radiation response by histone deacetylase inhibitionChinnaiyan, P. / Vallabhaneni, G. / Armstrong, E. et al. | 2005
- 230
-
Chronomodulation of topotecan or X-radiation treatment increases treatment efficacy without enhancing acute toxicityMullins, D. / Proulx, D. / Saoudi, A. et al. | 2005
- 238
-
Influence of different breathing maneuvers on internal and external organ motion: Use of fiducial markers in dynamic MRIPlathow, C. / Zimmermann, H. / Fink, C. et al. | 2005
- 246
-
Stereotactic radiosurgery for brain AVMs: Role of interobserver variation in target definition on digital subtraction angiographyBuis, D. R. / Lagerwaard, F. J. / Barkhof, F. et al. | 2005
- 253
-
RTOG title page| 2005
- 254
-
Foreword: Normal tissue biologic response modifiersOkunieff, P. et al. | 2005
- 255
-
Recent progress in defining mechanisms and potential targets for prevention of normal tissue injury after radiation therapyAnscher, M. S. / Chen, L. / Rabbani, Z. et al. | 2005
- 260
-
Interleukin (IL)-1A and IL-6: Applications to the predictive diagnostic testing of radiation pneumonitisChen, Y. / Hyrien, O. / Williams, J. et al. | 2005
- 267
-
Regulation of prostaglandin E2 synthesis after brain irradiationMoore, A. H. / Olschowka, J. A. / Williams, J. P. et al. | 2005
- 273
-
Mechanism and modification of gastrointestinal soft tissue response to radiation: Role of growth factorsOkunieff, P. / Cornelison, T. / Mester, M. et al. | 2005
- 279
-
Molecular targets in radiation-induced blood-brain barrier disruptionNordal, R. A. / Wong, C. S. et al. | 2005
- 288
-
Practical essentials of intensity modulated radiation therapyShimm, D. S. et al. | 2005
- 289
-
Fractionation and late rectal toxicity: No reliable estimates of α/β value for rectum can be derived from studies where different volumes of rectum are irradiated at different dose levels: In regard to Brenner (Int J Radiat Oncol Biol Phys 2004;60:1013–1015.)Fiorino, C. / Sanguineti, G. / Valdagni, R. et al. | 2005
- 290
-
In response to Dr. Fiorino et al.Brenner, D. J. et al. | 2005
- 291
-
Androgen Deprivation (AD) among low-risk and intermediate-risk prostate cancer patients: In regard to Ciezki et al. (Int J Radiat Oncol Biol Phys 2004;60:1347–1350)Oton, C. A. et al. | 2005
- 292
-
A career pathway for radiation therapists. Does it really exist?: In regard to Kresl et al. (Int J Radiat Oncol Biol Phys 2004;60:8–14)Malicki, J. et al. | 2005
- 292
-
In response to Dr. OtonCiezki, J. P. et al. | 2005
- 293
-
In response to Dr. MalickiKresl, J. J. et al. | 2005
- 293
-
Recommendations for image-based intracavitary brachytherapy of cervix cancer: The GYN GEC ESTRO Working Group point of view: In regard to Nag et al. (Int J Radiat Oncol Biol Phys 2004;60:1160–1172)Pö / tter, R. / Dimopoulos, J. et al. | 2005
- 295
-
In response to Dr. Potter et al.Nag, S. / Cardenes, H. / Chang, S. et al. | 2005
- 296
-
Lack of survival benefit after stereotactic radiosurgery boost for glioblastoma multiforme: Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: Report of radiation therapy oncology group 93-05 protocol: In regard to Souhami et al. (Int J Radiat Oncol Biol Phys 2004;60:853–860)Vordermark, D. / Kö / lbl, O. et al. | 2005
- 297
-
Permanent alopecia after cranial irradiation: Dose-response relationship: In regards to Lawenda et al. (Int J Radiat Oncol Biol Phys 2004;60:879–886)Goffman, T. E. et al. | 2005
- 297
-
In response to Drs. Vordermark and KölblSouhami, L. / Podgorsak, E. B. / Mehta, M. P. et al. | 2005
- 298
-
In response to Dr. GoffmanLoeffler, J. S. et al. | 2005
- 298
-
Radiobiological parameters suitable for modeling individual outcomes cannot be obtained by analyzing heterogeneous population data with homogeneous tumor control model: In regard to D’Souza et al. (Int J Radiat Oncol Biol Phys 2004;58:1540–1548)Carlone, M. / Wilkins, D. / Raaphorst, G. P. et al. | 2005
- 299
-
Can a mathematical formula help define a radiation target volume using positron emission tomography? In regard to Black et al. (Int J Radiat Oncol Biol Phys 2004;60:1272–1282)Bayne, M. / MacManus, M. / Hicks, R. et al. | 2005
- 300
-
In response to Dr. Bayne et al.Yan, D. / Grills, I. S. / Kestin, L. L. et al. | 2005
- 301
-
Meetings| 2005